Please login to the form below
BioMarin
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.
ACPs to lead gene therapies in haemophilia market growth
BioMarin’s ValRox, which is expected to launch as early as 2020, and Spark Therapeutics’ SPK-8011 for haemophilia A, and uniQure’s AMT-061 and Pfizer/Spark Therapeutics’ SPK-9001 ... Therefore, first-to-market advantage will drive commercial
New results back Sangamo, UniQure haemophilia gene therapies
The two firms are competing with BioMarin and Roche/Spark to bring gene therapies for haemophilia A to market, which could free patients with the disease from having to take regular ... It’s a case of so far, so good with SB-525 as Sangamo and Pfizer
Creating the Childhood Dementia Coalition and Platform
by Portland PR Ltd for BioMarin. Childhood dementia is a devastating disease, with parents watching their children gradually lose the ability to speak, see and walk. ... Creating the Childhood Dementia Coalition and Platform - by Portland PR Ltd for
Driving Awareness with the Dementia Strikes Children Too Campaign
The campaign by Portland PR and BioMarin employed targeted location based advertising very well, with striking visuals and measurable outcomes. ... Driving Awareness with the Dementia Strikes Children Too Campaign - by Portland PR for BioMarin.
Hidden MS
for BioMarin. ... Creating the Childhood Dementia Coalition and Platform by Portland PR Ltd - for BioMarin.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
